|
|
16-Night New Zealand CME AWAY® Cruise
Auckland, New Zealand • Bay Of Islands, New Zealand • Kingston, Norfolk Island, New Zealand • New Plymouth, New Zealand • Milford Sound, New Zealand • Dunedin, New Zealand • Akaroa, New Zealand • Wellington, New Zealand • Nelson, New Zealand • Picton, New Zealand • Napier, New Zealand • Tauranga, New Zealand |
|
|
7-Night Jamaica CME AWAY® Resort - Pearls for Managing Different Kinds of Arthritis, Sleep Disorders & Communicating with Patients
The all-new Sandals South Coast is the perfect combination of European civility in anall-beachfront resort. From all-new Over-the-Water Bungalows, an overwater bar, and a romantic Over-the-Water Chapel, Sandals South Coast brings guests closer than ever to the water. Set on a 2-mile stretch of Jamaica's south coast's most pristine white-sand beach and nestled within a 500-acre nature preserve, this spectacular seaside oasis features three distinctive European Villages. Relax by one of three po... |
|
|
Modern Medical Glaucoma Exploring the Trends
This webcast focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webcast also includes case discussions. Please also enjoy the perviously recorded question-and-answer session with Drs. Ian Benjamin Gaddie and Gagan Sawhney! |
|
|
Visualizing the Future of Presbyopia
Presbyopia is a natural result of aging, and eventually affects all individuals who reach an advanced age. This webinar includes discussions on the shortcomings of current treatments, clinical trial data on the emerging pharmaceutical options for the treatment of presbyopia, and patient selection for these novel therapies. |
|
|
International Experiences with New Presbyopia-Correcting IOLs – Enduring
This course is designed to educate ophthalmologists on the use of next generation presbyopia-correcting IOLs, including hybrids of advanced monofocals, EDOFs and multifocals from multiple manufacturers. Featuring first-hand accounts from an international group of faculty, US doctors will be able to learn about the next generation IOL designs and outcomes through real-world cases and group discussion. |
|
|
2020 Global Consensus on Corneal Irregularity
A panel of experts in ophthalmology from around the globe offer recommendations for defining, diagnosing, and treating irregular corneas.
Define etiology of irregular corneas, including natural occurring, surgically induced, disease, and/or trauma
Describe the prevalence of these types of irregular corneas’ etiology in various geographic regions and patient populations
Identify specific metric levels (surface regularity index and/or higher order aberrations) for diagnosing various grade... |
|
|
Advice from the Experts: Novel Treatments and Case Discussions in nAMD & GA
Join Drs. Jennifer Lim and Aleksandra Rachitskaya as they discuss challenging cases of geographic atrophy and age-related macular degeneration, current treatments, and how investigative therapies may change the way patients with these conditions are managed in the future. A live question-and-answer session will follow the presentation.
This certified CME activity is designed for retina specialists who manage patients with retinal diseases & other healthcare professionals involved in the man... |
|
|
Overcoming the Glaucoma Treatment Burden with Standalone and Combined MIGS
This 3-Hour No-Fee Live Interactive CE Credit course is designed to educate optometrists about the impact of glaucoma on the patient and the doctor and describe how minimally invasive glaucoma surgery (MIGS) options may help address drop burden and noncompliance issues at various levels of glaucoma progression. In this course, faculty will discuss how MIGS differs from traditional glaucoma surgical options and how it can be performed as a standalone procedure or combined with cataract surgery.... |
|
|
Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials
WEDNESDAY, FEBRUARY 24, 2021
9PM - 10PM ET (6PM - 7PM PT) |
|
|
Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient
This course is designed to educate ophthalmologists about new and emerging pharmacological treatments for pre-cataract presbyopic patients. This course will focus on the unique psychology of the pre-cataract presbyopia patient, details on evolving treatment options, and faculty will offer pearls for identifying candidates and mastering conversations with these patients throughout their journey.
Agenda:
6:00 - 6:05pm Welcome and Introduction
6:05 - 6:15pm Reviewing the Progression of P... |
|
|
Clinical and Pathological Benefits of Photobiomodulation
Join these experts from around the globe as they discuss the impact of dry age-related macular degeneration (AMD) and geographic atrophy (GA), the limitations of currently available treatments, and how novel therapies under investigation may have the potential to improve vision and quality of life for patients with dry AMD and GA. |
|
|
Photodynamic Therapy in 2020 and Beyond: Current Concepts for Real-World Use
Verteporfin for photodynamic therapy (PDT) has been in commercial use as a treatment for retinal disorders for several decades. Multiple studies have suggested a combination of anti-VEGF agents with PDT provides advantages over anti-VEGF monotherapy for polypoidal choroidal vasculopathy, but in wet AMD, the combination of PDT and anti-VEGF is not as clear-cut. This activity includes expert discussions on real-world clinical scenarios in which the use of PDT alone or in combination with anti-VE... |
|
|
Understanding, Diagnosing, and Treating Neurotrophic Keratitis in 2020
Eye care providers may not understand what neurotrophic keratitis is or how it differs from other corneal diseases. In addition; eye care practitioners may be unaware of treatments in development, or the already approved treatments for neurotrophic keratitis. They also may not understand the mechanism of action of these newer treatments. This supplement features four experts in neurotrophic keratitis who review important issues related to managing patients, including the scope and causes of th... |
|
|
Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies
The current state of neovascular age-related macular degeneration (nAMD) treatment in terms of anti-VEGF agents and the treatments expecting FDA approval on the near future are highlighted in this supplement. Faculty members also share their experiences in caring for patients during a pandemic. |
|
|
Targeting the Trabecular Meshwork: Incorporating New Outflow Drugs Into Glaucoma Care
Glaucoma is seeing a resurgence in innovative therapeutic developments. The recent approval of two drugs in novel classes for IOP reduction in eyes with ocular hypertension or open-angle glaucoma utilizes unique mechanisms of action not previously available with existing drug choices. This activity will provide education on the efficacy, safety, and mechanism of action of these two new drugs and how they compare to traditional glaucoma treatments. |
|
|
The Role of the Optometrist in the Evolving Management of Diabetic Retinopathy
The content featured in this supplement highlights the crucial role that optometrists play in educating patients with diabetes about the potential ocular complications of their systemic disorder, the additional care that must be addressed when undergoing ocular surgery (ie, cataract), and the benefits of diabetic eye exams and early treatment.
|
|
|
Targeting the Trabecular Meshwork: Collaborative Glaucoma Care
This supplement focuses on the comanagement of patients with glaucoma, specifically those who may be candidates for microinvasive glaucoma surgery procedures (MIGS) that target the trabecular meshwork, and the ways in which optometrists and ophthalmologists collaborate to provide the best pre- and postoperative care for these patients. |
|
|
Epidemiology of Dry AMD and GA
Geographic atrophy (GA) is an advanced form of age-related macula degeneration (AMD) for which there is currently no treatment approved by the US FDA. This supplement summarizes the latest information on GA, including the investigative therapies showing positive outcomes in clinical trials and insight from the expert faculty who share their expertise related to the optimal imaging modalities for evaluating GA and case studies. |
|
|
VBS Fellows Foray 2020
This CME-accredited program, originally planned for the 2020 VBS Annual Meeting, is now digital! Carefully selected cases will be presented by fellows from around the globe. Retina cases you would not believe! Real-world treatment strategies will be enthusiastically discussed among the esteemed panel members.
This truly unique series is designed for fellows, residents, and eye care specialists who recently entered practice and are involved in the management of patients with vitreoretinal di... |
|
|
Photodynamic Therapy: A Look at How This Treatment Fits Into Today’s Retina Practice
Eye care professionals may not know how to effectively identify patients in clinic who will benefit from Photodynamic Therapy (PDT), including those with persistent disease activity. This webinar includes discussions on real-world clinical scenarios in which the use of photodynamic therapy alone or in combination with anti-VEGFs can be a more efficacious treatment option than using anti-VEGFs alone, particularly in the setting of persistent disease activity.
|
|
|
Sustained Delivery of Anti-VEGF Agents: The Port Delivery System with Ranibizumab for the Treatment of Neovascular AMD
Arshad M. Khanani, MD, MA, and Peter A. Campochiaro, MD, discuss the latest available data on innovative sustained-release therapies for neovascular age-related macular degeneration, with a focus on the port delivery system with ranibizumab. |
|
|
Sustained Delivery of Anti-VEGF Agents: Gene Therapy for the Treatment of Neovascular AMD
Arshad M. Khanani, MD, MA, discusses with Christina Y. Weng, MD, MBA, how trial results differ from real-world experience with anti-VEGF injections of patients with neovascular age-related macular degeneration, and how gene therapy may fill various unmet needs in treating this disease. |
|
|
Sustained Delivery of Anti-VEGF Agents: Surgical Videos Highlighting Key Techniques
Arshad M. Khanani, MD, MA, and Carl D. Regillo, MD, discuss the current state of neovascular age-related macular degeneration treatments, the benefits of sustained-delivery of anti-VEGF agents, and additional treatments in development. This webinar also features surgical videos highlighting key techniques. |
|
|
Newest Available Treatments and Compounds in Development
Arshad M. Khanani, MD, MA; and Veeral Sheth, MD, discuss the current treatment regimens of patients with neovascular AMD and compare how disease management may change with therapies expected to gain FDA approval in the near future.
|
|
|
Wet AMD: Frequency of Dosing and Impact on Patient Outcomes
This program, featuring Arshad M. Khanani, MD, MA; and Diana V. Do, MD, highlights how dosing frequency for the treatment of wet AMD is changing based on pivotal clinical trials and real-world experience. They also discuss how the evolving treatment regimens may improve patient outcomes and help overcome challenges faced by patients and retina specialists with monthly dosing. |
|
|
The AMD Treatment Burden: The Problem and Possible Solutions
Arshad M. Khanani, MD, MA; and Nancy M. Holekamp, MD, review how the treatment of neovascular AMD has changed over the years, from thermal laser to different dosing strategies of anti-VEGFs, plus real-world experience with these regimens. They also discuss novel investigational therapies and how they are expected to have a positive impact on the lives of retina patients. |
|
|
What’s Next for nAMD? A Focus on Therapies in the Pipeline
Newer classes of drugs are being evaluated to treat age-related macular degeneration (AMD), along with longer duration of currently approved drugs. This supplement reviews the current status of AMD treatments and improved diagnostic technologies, with a focus on therapies in the pipeline. |
|
|
Neurotrophic Keratitis: Old Problem, New Solutions
Eye care providers may not understand what neurotrophic keratitis is or how it differs from other corneal diseases. In addition; eye care practitioners may be unaware of treatments in development, or the already approved treatments for neurotrophic keratitis. They also may not understand the mechanism of action of these newer treatments. |
|
|
Neurotrophic Keratitis: Disease Classifications and Therapy Options
Eye care providers may not understand what neurotrophic keratitis is or how it differs from other corneal diseases. In addition; eye care practitioners may be unaware of treatments in development, or the already approved treatments for neurotrophic keratitis. They also may not understand the mechanism of action of these newer treatments.
This webinar features four experts in neurotrophic keratitis who will discuss disease classification, practice patterns, and traditional therapies, as well... |
|
|
Retina Practice: Anti-VEGF Access and Reimbursement
This webinar is designed to address the challenges related to anti-VEGF access in retina practices. Hosted by retina specialists and retinal practice CEOs, the program will tackle both clinical and business-related issues including step therapy, MACRA/MIPS, payor-related obstacles, and more. A previously recorded live question-and-answer session will answer many of your questions and concerns. |
|
|
Addressing Challenges With Anti-VEGF Access
This webinar is designed to address the challenges related to anti-VEGF access in retina practices. Hosted by retina specialists and retinal practice CEOs, the program will tackle both clinical and business-related issues including step therapy, MACRA/MIPS, payor-related obstacles, and more. A previously recorded live question-and-answer session will answer many of your questions and concerns. |
|
|
The Business of Medical Retina: Overcoming Payor Challenges
Anti-VEGF therapy has revolutionized retinal care and turned many unavoidable blinding diseases into pathologies that can be controlled by restoring and preserving vision. Yet as the use of anti-VEGF medications continues to grow, so do the challenges of access to these medications. The following content showcases the challenges faced by physicians, practice administrators, and payors in the journey to providing quality care of patients with retinal disease. |
|
|
Exploring Emerging Trends in Medical Glaucoma Management
This webinar focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webinar also includes case discussions. |
|
|
The Changing Landscape of Glaucoma Therapies: Part 1
This webinar will focus on caring for patients with glaucoma and will highlight the ways in which sustained-release therapies can help extend the follow-up interval. In the age of a pandemic, the benefits of longer lasting treatments that increase patient compliance with fewer patients visits have never been more important. This webinar presents the same didactic material as part two, plus new case studies and a recorded question-and-answer session. |
|
|
What Have We Learned? Best Practices In The Management of DME Part 1
This webinar will focus on relevant and timely discussions about treating patients with diabetic retinopathy and diabetic macular edema. The COVID-19 pandemic has resulted in additional challenges for both patients and retina specialists. The esteemed panel, chaired by Sophie Bakri, MD, will examine clinical trial data and share their expertise on treatment options during these unprecedented times, methods for implementing treatment, and the role of inflammation, among other topics.
This webi... |
|
|
Managing Diabetic Macular Edema: Best Practices in Real-World Situations
This supplement focuses on relevant and timely discussions about treating patients with diabetic retinopathy (DR) and diabetic macular edema (DME). The COVID-19 pandemic has resulted in additional challenges for both patients and retina specialists. The esteemed faculty members examine clinical trial data and share their expertise on treatment options during these unprecedented times, methods for implementing treatment, and the role of inflammation, among other topics. |
|
|
Laser Refractive Surgery Options: How Do We Choose?
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
Refractive Surgery: Modern Methods
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
Glaucoma: Current Strategies for Detecting Disease Progression
This is part of a series of six webcasts that offer insight into topics that are important to eye care professionals in various subspecialties.
Focusing specifically on glaucoma management, two experts in the field share their expertise and advise how to optimize the way patients are monitored over time to detect disease progression. The importance of optic disc photos and OCT imaging, in addition to visual field progression and OCT progression will also be discussed, along with clinical ca... |
|
|
Practice Strategies and Imaging in the COVID Era
This is part of a series of six webcasts that offer insight into topics that are important to eye care professionals in various subspecialties.
The COVID-19 pandemic is continuing its global impact. In this webcast, two retina specialists discuss the ways they have adapted their practices and strategies for caring for patients while keeping their physicians and staff members safe. Also discussed is the key role of OCT imaging in retina practices and how the pandemic may generate innovative ... |
|
|
Imaging and Preoperative Evaluations
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
Geographic Atrophy: Expanding Our Understanding of the Disease and its Management
Geographic atrophy (GA) is an advanced form of age-related macular degeneration for which there is currently no treatment approved by the US FDA. This webinar will review in-depth the latest information on GA, including the investigative therapies showing positive outcomes in clinical trials. The expert faculty will also share their expertise related to the optimal imaging modalities for evaluating GA and share case studies for discussion. |
|
|
Adapting to Change: Incorporating Telemedicine into Our Practice
Although telemedicine is not new to ophthalmology, the 2020 coronavirus pandemic has heightened the need for options that keep patients and eye care providers safe. Eye care providers need to be educated on the changing regulations related to office visits and billing, the enhanced safety measures required, and the ocular conditions best suited for telemedicine. |
|
|
Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases
In this webinar, Drs. Arshad Khanani and Charles Wykoff unveil the latest clinical trial findings of gene therapies currently being explored for the treatment of neovascular diseases. They will discuss how these novel treatments compare to the current therapeutic options and how gene therapy could fill several unmet needs. |
|
|
Update in Glaucoma Treatment: An Emerging Frontier in Drug Delivery
In efforts to minimize compliance issues and improve overall patient adherence, researchers are evaluating sustained-release devices and methods to extend drug delivery. The first of these (for the treatment of glaucoma) dates to the 1970s. Numerous drug delivery systems/devices are currently marketed, and many others are in development. Several sustained-release devices that are in the pipeline include topical bimatoprost ocular insert, travoprost and latanoprost punctal plugs, latanoprost-el... |
|
|
The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond
Managing patients with retinal diseases is never simple, but with the COVID-19 pandemic, this challenge has become even more difficult as ophthalmologists are struggling to provide the best treatment while limiting office visits. Longer duration therapies are helping to meet those needs.
This webinar will focus on the latest data in diabetic macular edema treatment, comparing clinical trial versus real-world strategies, and the panel will discuss ways to adapt patient care in the COVID-19 e... |
|
|
Evolving Our Understanding and Management of Geographic Atrophy
This webinar will focus on the management of patients with geographic atrophy (GA). Join these well-known retina experts as they discuss the prevalence of GA, the risk factors for disease, ideal imaging modalities to diagnose and monitor its progression; and the growing pipeline of GA treatments and their mechanisms of action. The webinar will also feature case study discussions. |
|
|
Ocular Manifestations of Infectious Diseases in Children
Since the onset of the COVID-19 pandemic, national vaccination rates have dropped significantly, and there is concern about a potential rise in vaccine-preventable diseases (VPDs), especially in children. As members of the healthcare community, eye care providers should recognize that vaccines are the best way to protect themselves and their families, as well as their patients and coworkers. This webinar focuses on various systemic and ocular presentations of infectious diseases, with a focus ... |
|
|
NEW - Yachting the Seychelles Islands: Hot Topics in Medical, Dental & Public Health Issues
Yachting the Seychelles Islands
Hot Topics in Medical, Dental & Public Health Issues
Roundtrip Mahé on Crystal Esprit
March 19 – 26, 2023
Join PES and sail for 7 nights through the topaz waters of the Indian Ocean to the tropical paradise of the Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await.
Hot Topics in Medical, Dental & Public Health Issues
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Profes... |
|
|
NEW - Yachting the Seychelles Islands: Hot Topics in Medical, Dental & Public Health Issues
Yachting the Seychelles Islands
Hot Topics in Medical, Dental & Public Health Issues
Roundtrip Mahé on Crystal Esprit
February 13 – 20, 2022
Join PES and sail for 7 nights through the topaz waters of the Indian Ocean to the tropical paradise of the Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await.
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This Seminar is planned for 12 Continuing Ed... |
|